Key Takeaways
- Government raised ₹31,552 crore via LIC’s Offer for Sale, India’s largest public offering by issue size, lifting public shareholding to 10%, ahead of the May 2027 SEBI deadline
- CEO R Doraiswamy said another government stake sale is unlikely for 18–24 months; LIC has until May 2032 to meet the full 25% minimum public shareholding norm
- LIC’s Q1 FY27 net profit rose 22.81% YoY to ₹13,492 crore, with Value of New Business up 61.32% to ₹3,136 crore and VNB margin expanding 750 bps to 22.9% (from 15.4%); APE grew a more modest 8.22% to ₹13,692 crore
- LIC is evaluating fintech and insurtech investments and remains open to a health insurance entry, though Doraiswamy said there’s “no urgency”
- Bancassurance has grown from under 3% of new business in 2022 to over 8% now, with room to cross 10%, the CEO said
Check Live: LIC Option Chain (LICI) — Live OI, IV, Greeks & PCR
OFS Closes at ₹31,552 Crore, Public Float Hits 10%
The Centre raised ₹31,552 crore through an Offer for Sale in Life Insurance Corporation of India, the largest public offering in India’s capital markets by issue size. The two-day sale on August 4–5 was oversubscribed on both days, prompting the government to fully exercise its green shoe option and expand the offer from a 2.5% base to a 6.5% stake sale in total.
With this, LIC’s public shareholding has risen to 10%, meeting SEBI’s minimum public shareholding requirement well ahead of the May 16, 2027 deadline. CEO and MD R Doraiswamy told ET the OFS “shows the confidence the market has in LIC,” and that the insurer’s responsibility now is to live up to that expectation.
Next Stake Sale Unlikely Before 2028
LIC still has ground to cover on the broader 25% public shareholding norm, for which it holds a one-time exemption until May 2032. Doraiswamy said the government has indicated an 18–24-month gap before its next LIC stake sale, a pause he expects will ease the supply overhang and support better price discovery.
Why LIC Stock Still Trades Below Its Highs
LIC shares have struggled to hold gains since their May 2022 listing and slipped over 1% even as the OFS closed successfully, changing hands near ₹392–394, below both the 50-day and 200-day moving averages of roughly ₹420, and well off the 52-week high of ₹468.
Doraiswamy attributed part of the weakness to LIC’s historically low public float, pointing to the 1:1 bonus issue and a higher dividend payout as responses, alongside a consistent push toward non-par business and margin improvement.
VNB Margins Jump, APE Growth Stays Soft
LIC’s Value of New Business (VNB) climbed 61.32% year-on-year to ₹3,136 crore in Q1 FY27, with VNB margin expanding 750 basis points to 22.9% from 15.4% a year earlier, driven by a shift toward non-participating products, whose share of individual business rose to 32.49% from 30.34%. APE, however, grew a more modest 8.22% to ₹13,692 crore, lagging the broader industry.
Net premium income rose 6.75% to ₹1,27,250 crore, though LIC’s share of first-year premium income slipped to 60.10% from 63.51% a year earlier even as it retained market leadership. Doraiswamy said ULIP demand typically weakens during volatile market phases and that LIC is working to regain share there, adding that growth “requires a lot of effort because we operate on a very high base.” The annuity business also stayed weak in the quarter, which he linked to disrupted remittances and tighter liquidity.
Fintech, Health Insurance Plans Still on the Table
LIC is in the middle of a technology transformation and is engaging vendors as part of that push, Doraiswamy said, adding that the insurer is open to investing in fintech or insurtech companies that need growth capital.
On health insurance, he said LIC has not shelved the idea but is in no hurry: the claims settlement ratio “should not dent the brand that LIC carries,” he said, noting a few opportunities are under evaluation but none has reached a decision stage.
Bancassurance Crosses 8% of New Business
Business sourced through banks and alternative channels has grown from under 3% in 2022 to over 8% now, including digital, and could cross 10%, Doraiswamy said, while maintaining that the agency channel remains LIC’s core strength.
On the proposed IDBI Bank stake sale, he said the bank’s role as a bancassurance partner would continue regardless of LIC’s shareholding, even as LIC builds ties with other banks, brokers and web aggregators. On proposed trail-based commission reforms, he said LIC has already realigned payouts over multiple years and expects limited impact.
NiftyTrader Desk View
| Stock | Key Technical Trigger | Trader View |
|---|---|---|
| LIC (NSE: LICI) | Trading near ₹392–394, below both 50-DMA and 200-DMA (~₹420); 52-week range ₹360.75–₹468 | Stock remains in a corrective phase post-OFS; a sustained move back above the 50-DMA would be the first sign of trend reversal, while trade below key averages keeps the bias cautious |
Market Outlook
Doraiswamy described LIC’s investment approach as contrarian, buying on dips and booking profits on rallies, with a large fixed-income allocation locked in to capture elevated yields. On the broader market, he called the current phase range-bound and hard to call directionally given geopolitical uncertainty, but said both equity and debt offer opportunities at current levels.
Track daily institutional flows on the NiftyTrader FII-DII Tracker for real-time buying and selling data.
Bottom Line
LIC has cleared its most immediate regulatory hurdle by hitting the 10% public float mark, and Doraiswamy’s comments suggest the government will hold off on further dilution for at least a year and a half. The bigger swing factors, VNB margin trajectory, APE growth, and the fintech/health insurance bets, remain works in progress, which is likely to keep any re-rating gradual rather than immediate.
This article is for informational purposes only and does not constitute investment advice. Please consult a SEBI-registered financial advisor before making investment decisions.
